rs1800533
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001363.5(DKC1):c.*6G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.107 in 1,182,442 control chromosomes in the GnomAD database, including 5,806 homozygotes. There are 44,397 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.092 ( 516 hom., 3149 hem., cov: 23)
Exomes 𝑓: 0.11 ( 5290 hom. 41248 hem. )
Consequence
DKC1
NM_001363.5 3_prime_UTR
NM_001363.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.43
Genes affected
DKC1 (HGNC:2890): (dyskerin pseudouridine synthase 1) This gene functions in two distinct complexes. It plays an active role in telomerase stabilization and maintenance, as well as recognition of snoRNAs containing H/ACA sequences which provides stability during biogenesis and assembly into H/ACA small nucleolar RNA ribonucleoproteins (snoRNPs). This gene is highly conserved and widely expressed, and may play additional roles in nucleo-cytoplasmic shuttling, DNA damage response, and cell adhesion. Mutations have been associated with X-linked dyskeratosis congenita. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant X-154776873-G-A is Benign according to our data. Variant chrX-154776873-G-A is described in ClinVar as [Benign]. Clinvar id is 166995.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154776873-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.347 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DKC1 | NM_001363.5 | c.*6G>A | 3_prime_UTR_variant | 15/15 | ENST00000369550.10 | NP_001354.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DKC1 | ENST00000369550.10 | c.*6G>A | 3_prime_UTR_variant | 15/15 | 1 | NM_001363.5 | ENSP00000358563.5 |
Frequencies
GnomAD3 genomes AF: 0.0916 AC: 10180AN: 111102Hom.: 516 Cov.: 23 AF XY: 0.0945 AC XY: 3147AN XY: 33306
GnomAD3 genomes
AF:
AC:
10180
AN:
111102
Hom.:
Cov.:
23
AF XY:
AC XY:
3147
AN XY:
33306
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.147 AC: 23600AN: 161034Hom.: 1515 AF XY: 0.163 AC XY: 8330AN XY: 51120
GnomAD3 exomes
AF:
AC:
23600
AN:
161034
Hom.:
AF XY:
AC XY:
8330
AN XY:
51120
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.109 AC: 116583AN: 1071289Hom.: 5290 Cov.: 26 AF XY: 0.121 AC XY: 41248AN XY: 340227
GnomAD4 exome
AF:
AC:
116583
AN:
1071289
Hom.:
Cov.:
26
AF XY:
AC XY:
41248
AN XY:
340227
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0915 AC: 10172AN: 111153Hom.: 516 Cov.: 23 AF XY: 0.0944 AC XY: 3149AN XY: 33365
GnomAD4 genome
AF:
AC:
10172
AN:
111153
Hom.:
Cov.:
23
AF XY:
AC XY:
3149
AN XY:
33365
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 28, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 27% of patients studied by a panel of primary immunodeficiencies. Number of patients: 26. Only high quality variants are reported. - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Dyskeratosis congenita, X-linked Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at